ENVALITH
恵和株式会社 logo

KEIWA Incorporated

4251Prime MarketChemicals

恵和株式会社 logo
KEIWA Incorporated4251
Reference Indicators

Market Cap

235¥100M

P/E (Forecast)

P/B

0.9x

Dividend Yield (Forecast)

4.10%

ROE

9.7%

EV/EBITDA

2.8x
Financial Summary
Unit: ¥M
Item
2021Dec 2021
2022Dec 2022
2023Dec 2023
2024Dec 2024
2025Dec 2025
Net Sales
18,13021,10217,57021,13020,473
Cost of Sales
10,92410,91010,33211,24511,692
Gross Profit
7,20610,1917,2379,8848,781
SG&A Expenses
4,0714,6224,7825,1444,494
Operating Income
3,1355,5692,4554,7394,286
Non-operating Income
40471135952178
Non-operating Expenses
72785750125
Ordinary Income
3,4676,2022,7575,2104,240
Extraordinary Income
966161440
Extraordinary Losses
292119111,2871,016
Pre-tax Income
3,2716,6992,7603,9273,224
Income Taxes
7011,8387771,136955
Net Income
2,5694,8601,9832,7902,268
EBITDA
4,4837,0854,0456,4716,388
Gross Margin
39.7%48.3%41.2%46.8%42.9%
Operating Margin
17.3%26.4%14.0%22.4%20.9%
ROA
8.9%16.6%6.8%8.7%7.3%
ROE
24.1%29.4%10.1%12.9%9.7%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
光学製品事業16,7667,08542.3%
機能製品事業3,7072958.0%